Ketchum Adds Bayer Blood Test Product
Charting the future of public relations
Holmes Report
CEO

Ketchum Adds Bayer Blood Test Product

Oncogene Science, a research and development group that is part of Bayer Diagnostics, has selected Ketchum to provide public relations support for its serum HER-2/neu oncoprotein diagnostic assay.

Paul Holmes

NEW YORK, November23—Oncogene Science, a research and development group that is part of Bayer Diagnostics, has selected Ketchum to provide public relations support for its serum HER-2/neu oncoprotein diagnostic assay. This new blood test measures and monitors levels of HER-2/neu oncoprotein in women with metastatic breast cancer.
 
Ketchum will immediately begin handling communications to build awareness of the test within the oncology community.
 
“With a multitude of available treatment options and new therapies on the horizon, this innovative diagnostic can help guide clinical management, thus optimizing patient treatment,” said Diane Weiser, senior vice president and New York healthcare director for the agency. “We’re thrilled to apply our expertise in the fields of oncology, women’s health and diagnostics to educate physicians on this novel approach to breastcancer treatment management.”
 
Weiser will lead the account out of Ketchum’s New York office.
View Style:

Load 3 More
comments powered by Disqus